- Arvinas (New Haven, CT)
- …that ensures a successful launch. This position reports to the Senior Director of Breast Cancer Marketing and can be located at our headquarters in New ... treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer . Arvinas, as part of its...more information, please visit www.arvinas.com . **Position Summary** The Director of Marketing is accountable for developing… more
- Arvinas (New Haven, CT)
- …(ARV-471) for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer . Arvinas, as part of its overall business strategy, ... for initially supporting a successful US launch of vepdegestrant in ER+/HER2- metastatic breast cancer and future products through payer formulary access and… more
- Arvinas (New Haven, CT)
- …(ARV-471) for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer . Arvinas, as part of its overall business strategy, ... selectively assesses opportunities for potential collaboration, license, marketing and royalty arrangements, and similar transactions, to advance and accelerate the… more
- Arvinas (New Haven, CT)
- …(ARV-471) for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer . Arvinas, as part of its overall business strategy, ... selectively assesses opportunities for potential collaboration, license, marketing and royalty arrangements, and similar transactions, to advance and accelerate the… more
- Arvinas (New Haven, CT)
- …(ARV-471) for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer . Arvinas, as part of its overall business strategy, ... selectively assesses opportunities for potential collaboration, license, marketing and royalty arrangements, and similar transactions, to advance and accelerate the… more
- Arvinas (New Haven, CT)
- …(ARV-471) for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer . Arvinas, as part of its overall business strategy, ... selectively assesses opportunities for potential collaboration, license, marketing and royalty arrangements, and similar transactions, to advance and accelerate the… more